Whitney Snider

Whitney Snider is the Managing Partner of MSK Ventures at Memorial Sloan Kettering Cancer Center in New York City, where she leads investment strategy for early-stage healthcare startups. Before assuming this inaugural position, she spent six years at Alexandria Venture Investments, serving as Principal and Vice President of Life Sciences to source and lead strategic biotech investments. Her prior experience includes working as a Principal at Inning One Ventures, where she co-led the formation of Ajax Therapeutics, alongside business development positions at Celgene and management consulting roles at Bain & Company. Snider earned her Doctor of Medicine from Tufts University School of Medicine and a Master of Business Administration with High Distinction from Harvard Business School. Her career focuses on advancing early-stage life sciences, biotechnology, and oncology innovations from academic ecosystems into commercial therapeutic platforms.